BCRX Institutional Ownership & Shareholders
BIOCRYST PHARMACEUTICALS INC (BCRX) is currently held by 306 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.60B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of BCRX tracked by InsiderSet, reporting ownership valued at approximately $238.93M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $197.00M, representing an estimated loss of -17.55% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed BCRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Ra Capital Management, L.P., State Street Corp, and several other long-term asset managers with concentrated positions in BIOCRYST PHARMACEUTICALS INC (BCRX).
This page ranks the largest institutional BCRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
306
Total Reported Value
$2.60B
Largest Holder
Blackrock, Inc.
Largest Position
$238.93M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
46
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 23,893,036 | $238,930,360 | $196,998,082 | -$41,932,278 | -17.55% | |
| Ra Capital Management, L.P. | 1.38% | 15,827,186 | $158,271,860 | $130,495,149 | -$27,776,711 | -17.55% | |
| State Street Corp | 0.00% | 15,191,098 | $151,910,980 | $125,250,603 | -$26,660,377 | -17.55% | |
| Deerfield Management Company, L.P. | 1.57% | 15,096,403 | $150,964,030 | $124,469,843 | -$26,494,187 | -17.55% | |
| Vanguard Capital Management Llc | 0.00% | 11,364,236 | $113,642,360 | $93,698,126 | -$19,944,234 | -17.55% | |
| Vanguard Portfolio Management Llc | 0.01% | 11,139,158 | $111,391,580 | $91,842,358 | -$19,549,222 | -17.55% | |
| Tcg Crossover Management, Llc | 2.65% | 11,020,968 | $110,209,680 | $90,867,881 | -$19,341,799 | -17.55% | |
| Perceptive Advisors Llc | 1.60% | 10,308,888 | $103,088,880 | $84,996,782 | -$18,092,098 | -17.55% | |
| Janus Henderson Group Plc | 0.04% | 8,908,506 | $84,853,520 | $73,450,632 | -$11,402,888 | -13.44% | |
| Vestal Point Capital, Lp | 1.94% | 8,300,000 | $83,000,000 | $68,433,500 | -$14,566,500 | -17.55% | |
| Two Sigma Investments, Lp | 0.05% | 6,775,349 | $67,753,490 | $55,862,753 | -$11,890,737 | -17.55% | |
| Geode Capital Management, Llc | 0.00% | 6,248,046 | $62,493,232 | $51,515,139 | -$10,978,093 | -17.57% | |
| Aberdeen Group Plc | 0.07% | 5,310,871 | $53,108,710 | $43,788,131 | -$9,320,579 | -17.55% | |
| Ubs Group Ag | 0.01% | 5,078,280 | $50,782,800 | $41,870,419 | -$8,912,381 | -17.55% | |
| Bank Of America Corp | 0.00% | 4,801,284 | $48,012,840 | $39,586,587 | -$8,426,253 | -17.55% | |
| Goldman Sachs Group Inc | 0.00% | 4,481,874 | $44,818,738 | $36,953,051 | -$7,865,687 | -17.55% | |
| Frazier Life Sciences Management, L.P. | 0.87% | 4,009,240 | $40,092,400 | $33,056,184 | -$7,036,216 | -17.55% | |
| Nuveen, Llc | 0.01% | 4,007,237 | $40,072,370 | $33,039,669 | -$7,032,701 | -17.55% | |
| Millennium Management Llc | 0.02% | 3,394,729 | $33,947,290 | $27,989,541 | -$5,957,749 | -17.55% | |
| Gw&K Investment Management, Llc | 0.25% | 3,171,113 | $31,711,000 | $26,145,827 | -$5,565,173 | -17.55% | |
| Jane Street Group, Llc | 0.02% | 2,762,683 | $27,626,830 | $22,778,321 | -$4,848,509 | -17.55% | |
| Dimensional Fund Advisors Lp | 0.00% | 2,718,781 | $27,187,810 | $22,416,349 | -$4,771,461 | -17.55% | |
| Fisher Asset Management, Llc | 0.01% | 2,604,027 | $26,040,270 | $21,470,203 | -$4,570,067 | -17.55% | |
| Renaissance Technologies LLC | Jim Simons | 0.03% | 2,530,290 | $25,302,900 | $20,862,241 | -$4,440,659 | -17.55% |
| Kynam Capital Management, Lp | 1.39% | 2,522,660 | $25,226,600 | $20,799,332 | -$4,427,268 | -17.55% | |
| Candriam S.C.A. | 0.11% | 2,514,949 | $25,125,293 | $20,735,755 | -$4,389,538 | -17.47% | |
| Charles Schwab Investment Management Inc | 0.00% | 2,353,291 | $23,532,910 | $19,402,884 | -$4,130,026 | -17.55% | |
| Rice Hall James & Associates, Llc | 1.13% | 2,332,043 | $23,320,430 | $19,227,695 | -$4,092,735 | -17.55% | |
| Northern Trust Corp | 0.00% | 2,255,731 | $22,557,310 | $18,598,502 | -$3,958,808 | -17.55% | |
| Aqr Capital Management Llc | 0.01% | 2,214,302 | $22,143,020 | $18,256,920 | -$3,886,100 | -17.55% | |
| Morgan Stanley | 0.00% | 1,999,684 | $19,996,852 | $16,487,395 | -$3,509,457 | -17.55% | |
| Nantahala Capital Management, Llc | 1.15% | 1,901,160 | $19,011,600 | $15,675,064 | -$3,336,536 | -17.55% | |
| Eversept Partners, Lp | 1.02% | 1,865,653 | $18,656,530 | $15,382,309 | -$3,274,221 | -17.55% | |
| Orbimed Advisors Llc | 0.35% | 1,852,000 | $18,520,000 | $15,269,740 | -$3,250,260 | -17.55% | |
| Healthcare Of Ontario Pension Plan Trust Fund | 0.03% | 1,844,912 | $18,449,120 | $15,211,299 | -$3,237,821 | -17.55% | |
| Stifel Financial Corp | 0.02% | 1,826,234 | $18,262,340 | $15,057,299 | -$3,205,041 | -17.55% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,759,573 | $17,595,730 | $14,507,679 | -$3,088,051 | -17.55% | |
| Citadel Advisors Llc | 0.01% | 1,759,160 | $17,591,600 | $14,504,274 | -$3,087,326 | -17.55% | |
| Jupiter Asset Management Ltd | 0.08% | 1,642,874 | $16,428,740 | $13,545,496 | -$2,883,244 | -17.55% | |
| Imc-Chicago, Llc | 0.15% | 1,634,336 | $16,343,360 | $13,475,100 | -$2,868,260 | -17.55% | |
| Parkman Healthcare Partners Llc | 1.67% | 1,624,279 | $16,242,790 | $13,392,180 | -$2,850,610 | -17.55% | |
| Legal & General Group Plc | 0.00% | 1,455,514 | $14,555,141 | $12,000,713 | -$2,554,428 | -17.55% | |
| Invesco Ltd. | 0.00% | 1,233,783 | $12,337,830 | $10,172,541 | -$2,165,289 | -17.55% | |
| Susquehanna International Group, Llp | 0.01% | 1,195,651 | $11,956,510 | $9,858,142 | -$2,098,368 | -17.55% | |
| Pictet Asset Management Holding Sa | 0.01% | 1,249,771 | $11,951,392 | $10,304,362 | -$1,647,030 | -13.78% | |
| Op Asset Management Ltd | 0.12% | 1,252,863 | $11,927,256 | $10,329,855 | -$1,597,401 | -13.39% | |
| Bnp Paribas Financial Markets | 0.01% | 1,174,052 | $11,740,520 | $9,680,059 | -$2,060,461 | -17.55% | |
| First Trust Advisors Lp | 0.01% | 1,120,469 | $11,204,690 | $9,238,267 | -$1,966,423 | -17.55% | |
| Hrt Financial Lp | 0.02% | 1,081,523 | $10,815,000 | $8,917,157 | -$1,897,843 | -17.55% | |
| Moore Capital Management, Lp | 0.19% | 848,336 | $8,483,360 | $6,994,530 | -$1,488,830 | -17.55% |
Frequently asked questions about BCRX
Who are the largest institutional holders of BCRX?
The largest institutional holders of BCRX reported in the latest SEC Form 13F filings include Blackrock, Inc., Ra Capital Management, L.P., State Street Corp, Deerfield Management Company, L.P., and Vanguard Capital Management Llc. InsiderSet ranks institutional holders by their latest reported BCRX position.
What is BCRX institutional ownership?
This page tracks BCRX positions reported by institutional investment managers through SEC Form 13F. BIOCRYST PHARMACEUTICALS INC (BCRX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own BCRX?
InsiderSet currently tracks 306 institutional managers reporting BCRX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of BCRX shareholders.
How much BCRX stock do institutions own?
Institutional investment managers disclosed approximately $2.60B in BCRX holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was BCRX institutional ownership last updated?
The latest BCRX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional BCRX holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its BCRX position after the reporting date.
Are institutions buying or selling BCRX?
Institutional buying and selling can be analyzed by comparing BCRX positions across consecutive 13F reporting periods. InsiderSet's BCRX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View BCRX ownership changes.
How has BCRX institutional ownership changed over time?
InsiderSet tracks BCRX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.